DESCOVY
- Product NDC
- 70518-0230
- 11-digit product format
- 705180230
- Labeler code
- 70518
- Product ID
- 70518-0230_d332b82f-b08c-0350-e053-2995a90aa55a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- emtricitabine and tenofovir alafenamide fumarate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA208215
- Marketing category
- NDA
- Marketing start
- 2017-02-16
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
- Active strength
- 200 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0230-0 | 70518023000 | 30 TABLET in 1 BLISTER PACK (70518-0230-0) | 30 tablet | 2017-02-16 | 0000-00-00 | No | No | Current |